"Shkreli is the CEO of Retrophin, but he’s probably better known as the manager of MSMB. In that role, he has taken a vocal stand against a number of life sciences companies that he believes are not being managed properly, and he has even encouraged investors to bet the share prices of those firms would drop by “shorting” their stocks. His targets have ranged from small players like Cytori (NASDAQ: CYTX) and MannKind (NASDAQ: MKND) all the way up to giants like Pfizer (NYSE: PFE). Last summer, MSMB offered to buy troubled Lexington, MA-based AMAG (NASDAQ: AMAG) then led an effort to overthrow the board and have CEO Brian Pereira ousted. (Pereira later stepped down.)"

This slug made a living keeping medicine from people who needed it because he didn't think that the company was being managed properly.(Oh, coincidently he made a lot of money doing it.)How many people died from hypoglycemia that didn't have to if Afrezza was on the market a couple of years earlier.

Now he's trying to convince himself and us that it was noble and he's searching for an even better way to serve humanity.HA!!!!